A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis

Bibliographic Details
Main Authors:	McMullin, M, Mead, A, Ali, S, Cargo, C, Chen, F, Ewing, J, Garg, M, Godfrey, A, Knapper, S, McLornan, D, Nangalia, J, Sekhar, M, Wadelin, F, Harrison, C
Format:	Journal article
Published:	Wiley 2018

Similar Items

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
by: McMullin, M, et al.
Published: (2018)

Polycythaemia vera and central sleep apnoea.
by: Stradling, JR, et al.
Published: (1980)

Profile of polycythaemia vera in South Western Nigeria
by: Patrick Olanrewaju Osho, et al.
Published: (2022-01-01)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
by: Pavai Sthaneshwar, et al.
Published: (2023-10-01)

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients
by: Sergio Cabibbo, et al.
Published: (2024-10-01)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
by: ELMustafa Abdalla, et al.
Published: (2022-06-01)

Feasibility of recruitment of patients withMyeloproliferative Neoplasms into the TAPfunded TAMARIN study
by: Harrison, C, et al.
Published: (2018)

Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
by: McLornan, DP, et al.
Published: (2023)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
by: Jumoke Okikiolu, et al.
Published: (2023-01-01)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
by: Chartsiam Tipgomut, et al.
Published: (2021-11-01)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
by: Lewis Carpenter, et al.
Published: (2022-08-01)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
by: Abhinav Mathur, et al.
Published: (2022-11-01)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
by: Shanti Amé, et al.
Published: (2023-08-01)

Erythrocytosis associated with a novel missense mutation in the BPGM gene.
by: Petousi, N, et al.
Published: (2014)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
by: Bee, P.C., et al.
Published: (2010)

Allogeneic stem cell transplantation for myelofibrosis in 2012.
by: McLornan, D, et al.
Published: (2012)

Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis
by: Melanie J. Percy, et al.
Published: (2009-09-01)

Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial
by: Harrison, CN, et al.
Published: (2023)

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA
by: A. Segura Diaz, et al.
Published: (2022-06-01)

Polyglobulia Masquerading as Polycythaemia Vera Presenting as Superior Mesenteric Vein Thrombosis: A Case Report
by: Janhavi Nitin Mahajan, et al.
Published: (2022-10-01)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
by: Miguel Piris-Villaespesa, et al.
Published: (2021-01-01)

The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels
by: Melanie J. Percy, et al.
Published: (2007-12-01)

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis
by: Luz Martínez-Avilés, et al.
Published: (2007-12-01)

Screening for Latent Polycythemia Vera in Renal Cell Carcinoma–Associated Erythrocytosis
by: Stephen E. Langabeer
Published: (2023-04-01)

Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis
by: Alanna Barrios-Ruiz, et al.
Published: (2022-03-01)

Recurrent Episodes of Angioedema as Presenting Feature of JAK2-Positive Myeloproliferative Disorder Consistent with Polycythaemia Vera
by: Laith Al-Azrai, et al.
Published: (2021-07-01)

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
by: Camps, C, et al.
Published: (2016)

The janus kinase 2 (JAK2) mutation: A review of its role in polycythaemia vera and other myeloproliferative disorders
by: M U Nwagu
Published: (2011-01-01)

Guideline for the investigation and management of eosinophilia
by: Butt, N, et al.
Published: (2017)

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
by: Bassiony S, et al.
Published: (2020-09-01)

Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia
by: Keita Kirito, et al.
Published: (2024-07-01)

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
by: Campbell, P, et al.
Published: (2005)

Equivalence of BCSH and WHO diagnostic criteria for ET
by: Harrison, C, et al.
Published: (2016)

Serum erythropoietin in the evaluation of erythrocytosis: How much does it contribute to the diagnosis of polycythemia vera?
by: Ruchi Gupta, et al.
Published: (2023-01-01)

Cerebral venous sinus thrombosis in polycythaemia.
by: Thomson, D, et al.
Published: (2008)

Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
by: N. T. Weerasinghe, et al.
Published: (2021-12-01)

Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?
by: Maria Sarmento, et al.
Published: (2023-09-01)

A Difficult Case in Clinical Practice: Combined Polycythaemia Vera and Protein S Deficiency in a Patient with both Thrombotic and Bleeding Complications
by: Sushanth Wattal, et al.
Published: (2018-04-01)

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
by: Carme Camps, et al.
Published: (2016-11-01)

Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial
by: McPherson, S, et al.
Published: (2018)